Action NAVCO Pharmaceuticals - NAV

NAVCO Pharmaceuticals Inc (NAV) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,005

( - )

Prix Achat

0,005

Prix Vente

0,01

Volume échangé

Volume moyen (3 m)

$ 8 979

Volume financier

0,00 Fourchette du Jour 0,00

0,005 Plage de 52 semaines 0,01

Cap du marché

285,348k

Valeur d'Entreprise

389,222k

Clôture Veille

0,005

Ouverture

Dernière Transaction

Dernière heure de transaction

VWAP

Chiffre d'affairess (LTM)

Bénéfice net (LTM)

-73,26k

Actions en circulation

57 069 541

Flottant (%)

66,90%

Détention Institutionnelle (%)

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-3,9

Ratio Cours/Ventes (P/S)

Bénéfice par action (BPA)

-0

Bêta

2,22

NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard;... NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada. The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products. It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms. NAVCO Pharmaceuticals Inc. is headquartered in Vancouver, Canada. Show more

Secteur

Industrie

Site Web

navcopharma.com

Siège social

Vancouver, Canada

Fondé

NAVCO Pharmaceuticals Inc est coté dans le secteur de la TSX Venture Exchange avec le ticker NAV. Le dernier cours de clôture d'NAVCO Pharmaceuticals était de $0,01. Au cours de la dernière année, les actions de NAVCO Pharmaceuticals ont été négociées dans une fourchette de prix de $ 0,005 à $ 0,01.

NAVCO Pharmaceuticals compte actuellement 57 069 541 actions en circulation. La capitalisation boursière d'NAVCO Pharmaceuticals est de $285 347,71 . NAVCO Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -3.90.

TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, April 14, 2023 VANCOUVER, BC, April 14, 2023 /CNW/ - TSX VENTURE...

Pinetree Capital Ltd. Announces Unaudited Financial Results for the Three and Six Months Ended June 30, 2014

TORONTO, ONTARIO--(Marketwired - July 31, 2014) - Pinetree Capital Ltd. ("Pinetree") (TSX:PNP) today announces its unaudited interim consolidated...

Pinetree Capital Ltd. Announces Unaudited June 30, 2014 Net Asset Value Per Share of $0.78

TORONTO, CANADA--(Marketwired - July 15, 2014) - Pinetree Capital Ltd. (TSX:PNP) announces that as at June 30, 2014, Pinetree's unaudited net...

Goldman Sachs U.S. Income Builder Trust Announces Investment Update, Distributions and Distribution Reinvestment Plan

TORONTO, ONTARIO--(Marketwired - July 9, 2014) - Goldman Sachs U.S. Income Builder Trust (the "Fund") (TSX:GSB.UN) is pleased to announce that as...

Arcan Resources Ltd. Announces Strategic Transaction With Aspenleaf Energy Limited and Creation of A New Swan Hills Company

CALGARY, ALBERTA--(Marketwired - June 23, 2014) - NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF...

Canadian High Income Equity Fund Announces Distribution Reinvestment Plan

TORONTO, ONTARIO--(Marketwired - June 17, 2014) - Canadian High Income Equity Fund (the "Fund") (TSX:CIQ.UN) is pleased to announce that it has...

Pinetree Capital Ltd. Announces Unaudited May 31, 2014 Net Asset Value Per Share of $0.73

TORONTO, ONTARIO--(Marketwired - June 13, 2014) - Pinetree Capital Ltd. (TSX:PNP) announces that as at May 31, 2014, Pinetree's unaudited net...

Crocotta Energy Inc. Announces Strategic Transaction With Long Run Exploration and Creation of A New Pure-Play Montney Company

CALGARY, ALBERTA--(Marketwired - June 12, 2014) - NOT FOR DISTRIBUTION IN TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED...

Hyperion Exploration Corp. Announces First Quarter Results and Operations Update

CALGARY, ALBERTA--(Marketwired - May 29, 2014) - Hyperion Exploration Corp. ("Hyperion" or the "Company") (TSX VENTURE:HYX) announces it has filed...

Pinetree Capital Ltd. Announces Unaudited April 30, 2014 Net Asset Value Per Share of $0.83

TORONTO, CANADA--(Marketwired - May 15, 2014) - Pinetree Capital Ltd. (TSX:PNP) announces that as at April 30, 2014, Pinetree's unaudited net...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0.005	0.01	0.005	12480	0.008125	CS
4	-0.005	-50	0.01	0.01	0.005	8191	0.006253	CS
12	-0.005	-50	0.01	0.01	0.005	5158	0.00620811	CS
26	0	0	0.005	0.01	0.005	9791	0.00655232	CS
52	0	0	0.005	0.01	0.005	11721	0.0057801	CS
156	-0.045	-90	0.05	0.115	0.005	19169	0.02506094	CS
260	-0.445	-98.8888888889	0.45	0.45	0.005	18100	0.02601733	CS

NAV - Frequently Asked Questions (FAQ)

What is the current NAVCO Pharmaceuticals Inc share price?

The current share price of NAVCO Pharmaceuticals Inc is $ 0,005

How many NAVCO Pharmaceuticals Inc shares are in issue?

NAVCO Pharmaceuticals Inc has 57 069 541 shares in issue

What is the market cap of NAVCO Pharmaceuticals Inc?

The market capitalisation of NAVCO Pharmaceuticals Inc is CAD 285,35k

What is the 1 year trading range for NAVCO Pharmaceuticals Inc share price?

NAVCO Pharmaceuticals Inc has traded in the range of $ 0,005 to $ 0,01 during the past year

What is the PE ratio of NAVCO Pharmaceuticals Inc?

The price to earnings ratio of NAVCO Pharmaceuticals Inc is -3,9

What is the registered address of NAVCO Pharmaceuticals Inc?

The registered address for NAVCO Pharmaceuticals Inc is 1170 – 1040 West Georgia Street, Vancouver, British Columbia, V6E 4H1

What is the NAVCO Pharmaceuticals Inc website address?

The website address for NAVCO Pharmaceuticals Inc is navcopharma.com

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

NAVCO Pharmaceuticals Inc (NAV)

NAVCO Pharmaceuticals Inc (NAV) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de NAVCO Pharmaceuticals Inc

NAV Dernières nouvelles

TSX Venture Exchange Stock Maintenance Bulletins

Pinetree Capital Ltd. Announces Unaudited Financial Results for the Three and Six Months Ended June 30, 2014

Pinetree Capital Ltd. Announces Unaudited June 30, 2014 Net Asset Value Per Share of $0.78

Goldman Sachs U.S. Income Builder Trust Announces Investment Update, Distributions and Distribution Reinvestment Plan

Arcan Resources Ltd. Announces Strategic Transaction With Aspenleaf Energy Limited and Creation of A New Swan Hills Company

Canadian High Income Equity Fund Announces Distribution Reinvestment Plan

Pinetree Capital Ltd. Announces Unaudited May 31, 2014 Net Asset Value Per Share of $0.73

Crocotta Energy Inc. Announces Strategic Transaction With Long Run Exploration and Creation of A New Pure-Play Montney Company

Hyperion Exploration Corp. Announces First Quarter Results and Operations Update

Pinetree Capital Ltd. Announces Unaudited April 30, 2014 Net Asset Value Per Share of $0.83

NAV - Frequently Asked Questions (FAQ)

NAV Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

NAVCO Pharmaceuticals Inc (NAV)

NAVCO Pharmaceuticals Inc (NAV) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de NAVCO Pharmaceuticals Inc

NAV Dernières nouvelles

TSX Venture Exchange Stock Maintenance Bulletins

Pinetree Capital Ltd. Announces Unaudited Financial Results for the Three and Six Months Ended June 30, 2014

Pinetree Capital Ltd. Announces Unaudited June 30, 2014 Net Asset Value Per Share of $0.78

Goldman Sachs U.S. Income Builder Trust Announces Investment Update, Distributions and Distribution Reinvestment Plan

Arcan Resources Ltd. Announces Strategic Transaction With Aspenleaf Energy Limited and Creation of A New Swan Hills Company

Canadian High Income Equity Fund Announces Distribution Reinvestment Plan

Pinetree Capital Ltd. Announces Unaudited May 31, 2014 Net Asset Value Per Share of $0.73

Crocotta Energy Inc. Announces Strategic Transaction With Long Run Exploration and Creation of A New Pure-Play Montney Company

Hyperion Exploration Corp. Announces First Quarter Results and Operations Update

Pinetree Capital Ltd. Announces Unaudited April 30, 2014 Net Asset Value Per Share of $0.83

NAV - Frequently Asked Questions (FAQ)

NAV Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités